In all of our discussions on what 'gaps' need to be addressed under the MMPR, the lack of onsite distribution comes up again and again, and is one of the major reasons for the continued proliferation of dispensaries across Canada. It's certainly a more patient-focused option, where usually patients who access dispensaries are often given the option of coming in or having it mailed.
My work as a scientist involves researching the potential impact of cannabis among people living with HIV/AIDS. Patients have told us for decades that marijuana helps them deal with the side effects of their medications. But now, in a preliminary study, we have found evidence to suggest that people who use cannabis are more likely to have slower HIV disease progression -- meaning that they can live longer and healthier lives.
Last year Canada garnered global headlines when it made an historic shift to a federally legal, commercial medical cannabis industry. In the rush to establish new companies, produce consistent supply of quality products, and develop relationships with physicians and patients, the industry has failed to clearly articulate a common code of ethics.
I have dedicated my entire career to the health care industry because it's important to me to spend my life doing something that helps people. Now, after more than 25 years, I have decided to leave behind the big pharma establishment in order to embark on a new journey on the cutting edge of health care, as the first CEO of Tilray, Canada's leading licensed producer of medical cannabis. Here are the top five reasons why: Patients deserve better. Last year, Canada made history when it became one of the first countries in the world to create a federally-sanctioned, commercial medical cannabis industry that treats medical cannabis more like medicine than contraband.
Some major drawbacks with this new program (although there are many) include the reliance on mail/courier delivery as opposed to storefront sales, issues with affordability, the exclusion of sold extracts (such as hashish, oils, tinctures and edibles), and the loss of personal production rights more generally.
Health Canada has dropped one of the country’s first licensed pot companies from its roster of approved medical marijuana
If Health Canada spent as much time and money on researching medical marijuana and creating a properly run system as they have on court battles against patients, then we'd all be a lot better off. But unless you've just taken a big bong-hit, I wouldn't hold your breath.
A flurry of Canadian resource exploration companies are abandoning the dream of striking it rich in the gold rush in favour
Robert Davidson’s multiple sclerosis left him unable to walk for 15 years. He had prescriptions for 13 different drugs – including
The U.S.’s marijuana industry is poised to be among the fastest growing sectors of the economy, outpacing even the smartphone